Literature DB >> 18067604

Invitation to a debate on the serological criteria that define the antiphospholipid syndrome.

M Galli, G Reber, P de Moerloose, P G de Groot.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18067604     DOI： 10.1111/j.1538-7836.2007.02862.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  12 in total

1.  25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies.

Authors:  Laura Andreoli; Angela Tincani
Journal:  Intern Emerg Med       Date:  2009-01-08       Impact factor: 3.397

2.  APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.

Authors:  Brenda B Suh-Lailam; Anndorie Cromar; K Wayne Davis; Anne E Tebo
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

3.  Utility of Lupus Anticoagulant Assays (APTT-LA, KCT, DPT and DRVVT) in Detection of Antiphospholipid Syndrome (APS) in High Risk Pregnancy Cases.

Authors:  Ankur Ahuja; Seema Tyagi; Hara Prasad Pati; Renu Saxena; Venkatesan Somasundaram; Prabhu Manivannan; Preeti Tripathi; Dinesh Chandra
Journal:  Indian J Hematol Blood Transfus       Date:  2019-01-23       Impact factor: 0.900

Review 4.  Thrombotic risk in antiphospholipidic syndrome: From hypothesis to current evidence (Review).

Authors:  Claudia Mihaela Gavriș; Laurențiu Dănuț Nedelcu; Alina Mihaela Pascu
Journal:  Exp Ther Med       Date:  2021-01-26       Impact factor: 2.447

Review 5.  Mechanisms of antiphospholipid-induced thrombosis: effects on the protein C system.

Authors:  Denis Wahl; Aurélie Membre; Christine Perret-Guillaume; Véronique Regnault; Thomas Lecompte
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

6.  Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state.

Authors:  Jakub Swadzba; Teresa Iwaniec; Jacek Musial
Journal:  Rheumatol Int       Date:  2009-12-15       Impact factor: 2.631

7.  Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus.

Authors:  Selcan Demir; Jessica Li; Laurence S Magder; Michelle Petri
Journal:  Rheumatology (Oxford)       Date:  2021-08-02       Impact factor: 7.580

8.  Increased Performances of the Biological Diagnosis of the Antiphospholipid Syndrome by the Use of a Multiplex Assay.

Authors:  M Sénant; H Rostane; F Fernani-Oukil; F Hosking; F Bellery; A Courchinoux; E Tartour; L Darnige; M-A Dragon-Durey
Journal:  J Immunol Res       Date:  2015-05-06       Impact factor: 4.818

9.  Antiphospholipid antibodies and systemic scleroderma.

Authors:  Awa Oumar Touré; Fatimata Ly; Abibatou Sall; Alassane Diatta; Macoura Gadji; Moussa Seck; Blaise Faye; Tandakha Dieye; Saliou Diop
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

Review 10.  The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours?

Authors:  Emmanuel J Favaloro; Richard C W Wong
Journal:  Auto Immun Highlights       Date:  2010-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.